Your search returned 14 studies. (Get alerts for new studies):
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms - Stomach Neoplasms - Neoplasm Metastasis
2 Locations available
- Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer - Gastrointestinal Neoplasms - Colon Rectal Cancer Adenocarcinoma - Esophageal Cancer - Gall Bladder Cancer - Gastric (Stomach) Cancer - Gastrooesophageal Cancer - Gastrointestinal Stromal Tumor (GIST) - Hepatobiliary Neoplasm - Liver Ca
1 Location available
- Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma
Conditions: Gastric Cancer - Adenocarcinoma
26 Locations available
- Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
24 Locations available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma - Gastric Cancer
15 Locations available
- MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
135 Locations available
- Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
17 Locations available
- Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Stage IV Esophageal Cancer - Stage IV Gastric Cancer
2 Locations available
- Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
143 Locations available
- Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Conditions: Esophageal Adenocarcinoma - Gastric Adenocarcinoma
2 Locations available
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Conditions: Stomach Neoplasms - Esophageal Neoplasms
3 Locations available
- Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastro
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
204 Locations available
- A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
Conditions: Gastric Cancer
11 Locations available
|